1. Home
  2. NNNN vs FFA Comparison

NNNN vs FFA Comparison

Compare NNNN & FFA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Anbio Biotechnology Class A Ordinary Shares

NNNN

Anbio Biotechnology Class A Ordinary Shares

HOLD

Current Price

$9.25

Market Cap

417.8M

Sector

Health Care

ML Signal

HOLD

Logo First Trust Enhanced Equity Income Fund

FFA

First Trust Enhanced Equity Income Fund

HOLD

Current Price

$22.51

Market Cap

428.9M

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
NNNN
FFA
Founded
2021
N/A
Country
Germany
United States
Employees
27
N/A
Industry
Biotechnology: In Vitro & In Vivo Diagnostic Substances
Investment Managers
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
417.8M
428.9M
IPO Year
N/A
2004

Fundamental Metrics

Financial Performance
Metric
NNNN
FFA
Price
$9.25
$22.51
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
33.6K
19.9K
Earning Date
04-07-2026
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$446.57
N/A
Revenue Growth
N/A
N/A
52 Week Low
$8.30
$19.50
52 Week High
$54.90
$23.24

Technical Indicators

Market Signals
Indicator
NNNN
FFA
Relative Strength Index (RSI) 37.56 54.27
Support Level $8.30 $21.60
Resistance Level $29.98 $22.87
Average True Range (ATR) 1.31 0.20
MACD 0.58 -0.01
Stochastic Oscillator 33.89 60.24

Price Performance

Historical Comparison
NNNN
FFA

About NNNN Anbio Biotechnology Class A Ordinary Shares

Anbio Biotechnology is a medical device company focused on in vitro diagnostics. The company's mission is to change the diagnostics market by personalizing and decentralizing the current diagnostic solutions for faster diagnosis to improve patient prognosis. The company proposes this by providing accessible and affordable diagnostic solutions globally at the forefront of science and offering laboratory, wellness, at-home, and point-of-care (POCT) in vitro diagnostic (IVD) solutions. The business planning is to focus on validating and commercializing the existing portfolio of in vitro diagnostic products, as well as generating additional data required to support regulatory submissions and compliance, including under frameworks such as the In Vitro Diagnostic Regulation (IVDR).

About FFA First Trust Enhanced Equity Income Fund

First Trust Enhanced Equity Income Fund is a diversified, closed-end management investment company. Its investment objective is to provide high level of current income and gains and, to a lesser extent, capital appreciation. The Fund pursues its investment objective by investing in a diversified portfolio of equity securities.

Share on Social Networks: